242 related articles for article (PubMed ID: 23122956)
21. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
22. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
23. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
[TBL] [Abstract][Full Text] [Related]
24. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
25. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
26. Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Harris TL; McGargill MA
PLoS One; 2015; 10(5):e0123650. PubMed ID: 25951457
[TBL] [Abstract][Full Text] [Related]
27. Divergence and convergence of TGF-beta/BMP signaling.
Miyazono K; Kusanagi K; Inoue H
J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
[TBL] [Abstract][Full Text] [Related]
28. The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation.
Alvarez J; Horton J; Sohn P; Serra R
Dev Dyn; 2001 Jul; 221(3):311-21. PubMed ID: 11458391
[TBL] [Abstract][Full Text] [Related]
29. SARA is dispensable for functional TGF-β signaling.
Bakkebø M; Huse K; Hilden VI; Forfang L; Myklebust JH; Smeland EB; Oksvold MP
FEBS Lett; 2012 Sep; 586(19):3367-72. PubMed ID: 22819827
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
32. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
König HG; Kögel D; Rami A; Prehn JH
J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
[TBL] [Abstract][Full Text] [Related]
33. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
34. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation.
Droguett R; Cabello-Verrugio C; Santander C; Brandan E
Exp Cell Res; 2010 Sep; 316(15):2487-503. PubMed ID: 20471380
[TBL] [Abstract][Full Text] [Related]
36. TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells.
Cha Y; Kim DK; Hyun J; Kim SJ; Park KS
Cell Signal; 2013 May; 25(5):1245-51. PubMed ID: 23357533
[TBL] [Abstract][Full Text] [Related]
37. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
[TBL] [Abstract][Full Text] [Related]
38. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas.
Sebestyén A; Márk Á; Hajdu M; Nagy N; Molnár A; Végső G; Barna G; Kopper L
Cytokine; 2015 Jun; 73(2):219-24. PubMed ID: 25794661
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone inhibits TGF-β/Smad signaling and extracellular matrix proteins upregulation in rat mesangial cells.
Peng FF; Xiao ZL; Chen HM; Chen Y; Zhou J; Yu H; Zhang BF
Biochem Biophys Res Commun; 2016 Sep; 478(3):1093-8. PubMed ID: 27530924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
